AntINFECT: Application of bioengineering in the treatment of infected problematic wounds (Q2906960): Difference between revisions
Jump to navigation
Jump to search
(BatchIngestion) |
(Added qualifier: readability score (P590521): 0.000011549073841409742) |
||||||||||||||
| (One intermediate revision by the same user not shown) | |||||||||||||||
| Property / beneficiary name (string) | |||||||||||||||
| Property / beneficiary name (string): INEB-INSTITUTO NACIONAL DE ENGENHARIA BIOMEDICA / rank | |||||||||||||||
| Property / beneficiary | |||||||||||||||
| Property / beneficiary: Q2993187 (Deleted Item) / rank | |||||||||||||||
| Property / budget | |||||||||||||||
| |||||||||||||||
| Property / budget: 239,973.55 Euro / rank | |||||||||||||||
| Property / EU contribution | |||||||||||||||
| |||||||||||||||
| Property / EU contribution: 203,977.52 Euro / rank | |||||||||||||||
| Property / summary: None (English) / qualifier | |||||||||||||||
readability score: 0.000011549073841409742
| |||||||||||||||
| Property / co-financing rate | |||||||||||||||
| |||||||||||||||
| Property / co-financing rate: 85.0 percent / rank | |||||||||||||||
| Property / date of last update | |||||||||||||||
| |||||||||||||||
| Property / date of last update: 23 May 2023 / rank | |||||||||||||||
| Property / beneficiary | |||||||||||||||
| Property / beneficiary: INEB-INSTITUTO NACIONAL DE ENGENHARIA BIOMEDICA / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / beneficiary name (string) | |||||||||||||||
INEB-INSTITUTO NACIONAL DE ENGENHARIA BIOMEDICA | |||||||||||||||
| Property / beneficiary name (string): INEB-INSTITUTO NACIONAL DE ENGENHARIA BIOMEDICA / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / budget | |||||||||||||||
234,404.94 Euro
| |||||||||||||||
| Property / budget: 234,404.94 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
| Property / EU contribution | |||||||||||||||
199,244.2 Euro
| |||||||||||||||
| Property / EU contribution: 199,244.2 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
| Property / co-financing rate | |||||||||||||||
85.0 percent
| |||||||||||||||
| Property / co-financing rate: 85.0 percent / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / date of last update | |||||||||||||||
14 November 2023
| |||||||||||||||
| Property / date of last update: 14 November 2023 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 17:40, 22 March 2024
Project Q2906960 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | AntINFECT: Application of bioengineering in the treatment of infected problematic wounds |
Project Q2906960 in Portugal |
Statements
199,244.2 Euro
0 references
234,404.94 Euro
0 references
85.0 percent
0 references
7 January 2018
0 references
30 June 2022
0 references
INEB-INSTITUTO NACIONAL DE ENGENHARIA BIOMEDICA
0 references
41°8'58.02"N, 8°36'38.84"W
0 references
Porto
0 references
14 November 2023
0 references
Identifiers
POCI-01-0145-FEDER-031781
0 references